166 related articles for article (PubMed ID: 35517865)
1. The Okur-Chung Neurodevelopmental Syndrome Mutation CK2
Caefer DM; Phan NQ; Liddle JC; Balsbaugh JL; O'Shea JP; Tzingounis AV; Schwartz D
Front Mol Biosci; 2022; 9():850661. PubMed ID: 35517865
[TBL] [Abstract][Full Text] [Related]
2. Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2α
Werner C; Gast A; Lindenblatt D; Nickelsen A; Niefind K; Jose J; Hochscherf J
Front Mol Biosci; 2022; 9():831693. PubMed ID: 35445078
[TBL] [Abstract][Full Text] [Related]
3. Predictive functional, statistical and structural analysis of
Unni P; Friend J; Weinberg J; Okur V; Hochscherf J; Dominguez I
Front Mol Biosci; 2022; 9():851547. PubMed ID: 36310603
[TBL] [Abstract][Full Text] [Related]
4. [A case of Okur-Chung syndrome caused by CSNK2A1 gene variation and review of literature].
Duan HL; Peng J; Pang N; Chen SM; Xiong J; Guang SQ; Yin F
Zhonghua Er Ke Za Zhi; 2019 May; 57(5):368-372. PubMed ID: 31060130
[No Abstract] [Full Text] [Related]
5. Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome-Two Sides of the Same Coin?
Ballardin D; Cruz-Gamero JM; Bienvenu T; Rebholz H
Front Mol Biosci; 2022; 9():850559. PubMed ID: 35693553
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Okur-Chung Neurodevelopmental Syndrome: Case Report and Literature Review.
Jafari Khamirani H; Zoghi S; Motealleh A; Dianatpour M; Tabei SMB; Mohammadi S; Dastgheib SA
Mol Syndromol; 2022 Dec; 13(5):381-388. PubMed ID: 36588763
[TBL] [Abstract][Full Text] [Related]
7. Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.
Dominguez I; Cruz-Gamero JM; Corasolla V; Dacher N; Rangasamy S; Urbani A; Narayanan V; Rebholz H
Hum Genet; 2021 Jul; 140(7):1077-1096. PubMed ID: 33944995
[TBL] [Abstract][Full Text] [Related]
8. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome-A clinical study of 11 individuals.
Owen CI; Bowden R; Parker MJ; Patterson J; Patterson J; Price S; Sarkar A; Castle B; Deshpande C; Splitt M; Ghali N; Dean J; Green AJ; Crosby C; ; Tatton-Brown K
Am J Med Genet A; 2018 May; 176(5):1108-1114. PubMed ID: 29383814
[TBL] [Abstract][Full Text] [Related]
9. A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the
Zhuri D; Dusenkalkan F; Tunca Alparslan G; Gurkan H
Mol Syndromol; 2024 Feb; 15(1):43-50. PubMed ID: 38357263
[TBL] [Abstract][Full Text] [Related]
10. Inherited CSNK2A1 variants in families with Okur-Chung neurodevelopmental syndrome.
Belnap N; Price-Smith A; Ramsey K; Leka K; Abraham A; Lieberman E; Hassett K; Potu S; Rudy N; Smith K; Mikhail FM; Monaghan KG; Hendershot A; Mourmans J; Descartes M; Huentelman MJ; Sills J; Rangasamy S; Narayanan V
Clin Genet; 2023 Nov; 104(5):607-609. PubMed ID: 37491870
[TBL] [Abstract][Full Text] [Related]
11. Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome.
Murakami H; Uehara T; Enomoto Y; Nishimura N; Kumaki T; Kuroda Y; Asano M; Aida N; Kosaki K; Kurosawa K
Mol Syndromol; 2022 Feb; 13(1):75-79. PubMed ID: 35221879
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel
Wu RH; Tang WT; Qiu KY; Li XJ; Tang DX; Meng Z; He ZW
J Int Med Res; 2021 May; 49(5):3000605211017063. PubMed ID: 34038195
[No Abstract] [Full Text] [Related]
13. Okur-Chung neurodevelopmental syndrome in a patient from Spain.
Martinez-Monseny AF; Casas-Alba D; Arjona C; Bolasell M; Casano P; Muchart J; Ramos F; Martorell L; Palau F; García-Alix A; Serrano M
Am J Med Genet A; 2020 Jan; 182(1):20-24. PubMed ID: 31729156
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
[TBL] [Abstract][Full Text] [Related]
15. Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome.
Akahira-Azuma M; Tsurusaki Y; Enomoto Y; Mitsui J; Kurosawa K
Hum Genome Var; 2018; 5():18011. PubMed ID: 29619237
[TBL] [Abstract][Full Text] [Related]
16. Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.
Luz S; Kongsuphol P; Mendes AI; Romeiras F; Sousa M; Schreiber R; Matos P; Jordan P; Mehta A; Amaral MD; Kunzelmann K; Farinha CM
Mol Cell Biol; 2011 Nov; 31(22):4392-404. PubMed ID: 21930781
[TBL] [Abstract][Full Text] [Related]
17. The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2.
Costa R; Arrigoni G; Cozza G; Lolli G; Battistutta R; Izpisua Belmonte JC; Pinna LA; Sarno S
Biochim Biophys Acta; 2014 Apr; 1844(4):722-9. PubMed ID: 24486797
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter.
Roosbeek S; Peelman F; Verhee A; Labeur C; Caster H; Lensink MF; Cirulli C; Grooten J; Cochet C; Vandekerckhove J; Amoresano A; Chimini G; Tavernier J; Rosseneu M
J Biol Chem; 2004 Sep; 279(36):37779-88. PubMed ID: 15218032
[TBL] [Abstract][Full Text] [Related]
19. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
Lebrin F; Chambaz EM; Bianchini L
Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
[TBL] [Abstract][Full Text] [Related]
20. Mutation of recombinant catalytic subunit alpha of the protein kinase CK2 that affects catalytic efficiency and specificity.
Chaillot D; Declerck N; Niefind K; Schomburg D; Chardot T; Meunier JC
Protein Eng; 2000 Apr; 13(4):291-8. PubMed ID: 10810161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
